FindTrial
Sign In

Effects of intravenous infusion of remazolam and dexmedetomidine on patients undergoing endoscopic sinus surgery

Effects of intravenous infusion of remazolam and dexmedetomidine on patients undergoing endoscopic sinus surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076209
Enrollment
Unknown
Registered
2023-09-27
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic sinusitis

Interventions

Remazolam group( Group R):Intravenous infusion of remazolam
Dexmedetomidine group (Group D):Intravenous infusion of dexmedetomidine
Control group (Group C):Intravenous infusion of equal amounts of normal saline

Sponsors

Anqing Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? ASA grade ? ~ ?;? Age: 18 ~ 65 years old;? Endoscopic sinus surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: Preoperative complications of systemic diseases (including neuropsychiatric diseases, cardiopulmonary diseases, etc.); ? Recent acute upper ?respiratory tract infection or lung infection; ? Take any sedative drugs before surgery; Have a history of food or drug allergies; ? Patients refused to participate in the study.

Design outcomes

Primary

MeasureTime frame
postoperative agitation;Postoperative sleep quality;Postoperative recovery quality;VAS pain score;—

Secondary

MeasureTime frame
cough;Amount of bleeding;—

Countries

China

Contacts

Public ContactShenghong Hu

Anqing Municipal Hospital

hsh0312@yeah.net+86 139 5651 1825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026